Celiac disease requires a well-defined, lifelong first-line intervention. The structured protocol specifies exactly what that intervention entails, which dietary elements are included or excluded, and what measurable responses confirm treatment is working.
Management is built around a lifelong dietary modification that demands strict, consistent adherence. The protocol details the precise composition of this diet and which food components must be completely avoided from the point of diagnosis.
Treatment response is tracked across three dimensions: symptom relief, serological markers (including IgA anti-TG2 titre trajectory), and mucosal healing. Response timelines show substantial inter-individual variability, spanning from weeks to approximately one year depending on the outcome measure.
DOI: 10.1002/ueg2.70195
The treatment for CeD is a lifelong adherence to a GFD. Strict adherence is essential for controlling symptoms, improving QoL, and reducing the risk of long‑term complications.
The only effective treatment for CeD is lifelong, strict adherence to a GFD, requiring complete exclusion of wheat, rye, and barley.
Only certified gluten‑free oats are safe and should be recommended for people with CeD and can be included from diagnosis as part of a well‑balanced GFD.
Clinical response to a GFD in adults with CeD shows substantial inter‑individual variability, with symptom improvement generally expected within 4 weeks to 4–5 months after diet initiation.
A decline in IgA anti‑TG2 can be observed as early as 2–4 weeks after starting a GFD, and in the majority, titres normalize within approximately 12 months.
Healing of the duodenal mucosa is generally expected around 1 year after starting a GFD.